Sign in

You're signed outSign in or to get full access.

Anne Murphy

Director at IVP
Board

About Anne Murphy

Anne Murphy (age 59) is an independent director of Inspire Veterinary Partners, Inc. (IVP), serving since August 2023; she is a technology and transformation leader with 30+ years across utility, retail, direct-to-consumer, and veterinary sectors, and currently Vice President, Business Solutions and Applications at American Electric Power . Her prior roles include CIO positions at Best Buy Health/GreatCall and Banfield Pet Hospital, senior technology leadership at Target, and owner/president of consulting firm Claro Vista LLC; she holds an MBA from University of St. Thomas (2004) and a BS from Metropolitan State University (1998) .

Past Roles

OrganizationRoleTenureCommittees/Impact
American Electric PowerVice President, Business Solutions and ApplicationsJan 2021 – PresentTechnology transformation leadership supporting utility operations
Best Buy Health / GreatCall, Inc.Chief Information OfficerNov 2017 – Mar 2020Led health tech platform operations/go-to-market
Banfield Pet HospitalChief Information Officer2015 – 2017CIO in veterinary services; technology modernization
Target CorporationTechnology VP/Senior Director2008 – 2014Enterprise retail systems leadership
Claro Vista LLCOwner & President2014 – PresentConsulting in tech/transformation across sectors

External Roles

OrganizationRoleTenureCommittees/Impact
United Through ReadingBoard Trustee & Operations Committee Chair2018 – PresentOperations oversight in nonprofit literacy
Banfield FoundationBoard Member2017Philanthropy in veterinary care
Habitat for Humanity Women’s BuildVolunteer2013 – 2014Community development support
Ordway Circle of StarsBoard Member2008 – 2010Arts organization governance

Board Governance

  • Independence: The Board determined Anne Murphy is an “independent director” under Nasdaq and SEC rules .
  • Committees: Compensation Committee member and Chair; not listed on Audit or Governance & Nominating in committee matrix .
  • Attendance: Board held 4 meetings in 2024; each director attended at least 75% of Board and committee meetings for their service period .
  • Executive sessions: Non-management directors meet in executive session at each quarterly board meeting; no Lead Independent Director .
  • Committee activity: Compensation Committee met 4 times in 2024 .

Fixed Compensation

ComponentAmountNotes
Annual retainer (cash)$36,000Payable monthly
Committee fee (cash)$5,000Annual fee for service on one or more committees
Meeting feesNone disclosedNo per-meeting fees disclosed
Total cash fees (2024)$41,000Anne Murphy’s fees earned in 2024

Performance Compensation

Award TypeGrant DateShares/UnitsExercise/StrikeVestingGrant Date Fair ValueNotes
Stock options (Class A)Sep 26, 20241,447$17.00Fully vested at grant$3,618Options granted to non-employee directors; exercise price equals Nasdaq close; adjusted for 1-for-25 reverse split in Jan 2025
RSUsNot disclosedNo RSUs disclosed for directors
PSUsNot disclosedNo PSUs disclosed for directors

Performance metrics tied to director compensation: None disclosed (director pay comprised of fixed retainers and fully vested options; no performance-conditioned equity for directors) .

Other Directorships & Interlocks

  • Current public company boards: Not disclosed in the proxy for Anne Murphy .
  • Interlocks/conflicts: None disclosed for Anne Murphy; broader company related-party items involve other directors and the CEO (see Governance Assessment) .

Expertise & Qualifications

  • Education: MBA, University of St. Thomas (2004); BS, Metropolitan State University (1998) .
  • Technical and leadership expertise: CIO roles in health tech and veterinary services; senior technology leadership in large retail; transformation and applications leadership in utilities; consulting practice owner .
  • Board qualifications cited: Multi-decade technology/administration experience across veterinary services and other industries; demonstrated commitment to public service .

Equity Ownership

ClassBeneficially Owned SharesNature of OwnershipPercent of Class
Class A common1,447Options exercisable at $17; fully vested and counted as beneficial ownership within 60 days Less than 1%
Class B commonNone

Options breakdown (as of Dec 31, 2024):

  • Outstanding options: 1,447; Unvested: 0 .
  • Section 16(a) note: One late report for directors covering option grant reporting (includes Ms. Murphy) due to inadvertent administrative error .

Governance Assessment

  • Compensation Committee Chair: Anne Murphy chairs the Compensation Committee, responsible for executive and director pay and equity plan administration; the committee met 4 times in 2024 and may retain independent advisors, with direct appointment/oversight responsibility—positive for pay governance .
  • Independence and engagement: Independent status, with at least 75% meeting attendance in 2024; non-management executive sessions occur quarterly, supporting oversight of management .
  • RED FLAG – Hedging/Pledging policy: Company has not adopted prohibitions on short sales, options/derivatives, margin accounts, or pledging for directors/officers/employees, which weakens alignment safeguards .
  • Board leadership structure: Combined CEO/Chair and no Lead Independent Director; while evaluated annually, this structure concentrates authority and may constrain independent board leadership—monitor compensations committee’s counterbalance role .
  • Related-party environment: Disclosed related-party engagements involve other directors/CEO (e.g., Blue Heron Consulting, Star Circle Advisory; clinic sale to entity linked to director’s family), with Audit Committee oversight—heightens needs for strong independent committee scrutiny; no Anne-specific transactions disclosed .
  • Compliance signal: One late Section 16(a) filing for option grant reporting among several directors including Ms. Murphy; attributed to administrative error—minor process weakness to monitor .